Efficacy of Nanoparticle Albumin-Bound Paclitaxel (nab-PTX) Monotherapy Can Be Improved after Treatment with Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer: Long-Term Follow-Up and Updated Analysis of Two Previous Prospective Clinical Studies.

Koki NakashimaYukihiro UmedaYoshiki DemuraTomoaki SonodaToshihiko TadaMakiko YamaguchiMasaki AnzaiMaiko KadowakiMasahiro OiChisato HonjoMiho MitsuiYuko WasedaTamotsu Ishizuka

Published in: Oncology (2024)

Nab-PTX monotherapy may be an effective subsequent treatment option after ICI treatment.

Keyphrases

combination therapy
advanced non small cell lung cancer
open label
clinical trial
tyrosine kinase
replacement therapy
study protocol
childhood cancer